Summary
The theoretical principles are outlined for estimating the fraction of a drug undergoing first-pass metabolism using only the plasma levels found after a single oral dose. Data for 3 drugs are used to illustrate the method. It involves analysis of the parent drug and the metabolite formed during the first passage through the gut wall and liver and evaluation of their total mean times. The mean time characteristics of molsidomine, nortriptyline and propranolol are considered and they confirm the theoretically deduced dependency of the mean time of the parent drug and the metabolite. Whether the results are more precise than those obtained from comparison of areas after oral and intravenous administration is discussed. From the data presented it is clear that the mean time method depends on the scatter inherent in the data. In order to estimate the true first-pass effect, greater scatter requires an increased number of data pairs, i.e. subjects. If intravenous data are not available, however, the method described provides a rough but worthwhile estimate of the first pass effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alván G, Borgå O, Lind M, Palmér L, Siwers B (1977) First pass hydroxylation of nortriptyline: Concentrations of parent drug and major metabolites in plasma. Eur J Clin Pharmacol 11: 219–224
Brockmeier D (1984) In vitro — in vivo correlation, a time scaling problem? Evaluation of mean times. Arzneimittelforsch/Drug-Res 34 [II]: 1604–1607
Chan KK (1982) A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory. Drug Metab Dispos 10: 474–479
Dell D, Chamberlain J (1978) Determination of molsidomine in plasma by high performance liquid column chromatography. J Chromatogr 146: 465–472
Gibaldi M, Boyes RN, Feldman S (1971) Influence of first pass effect on availability of drugs on oral administration. J Pharm Sci 60: 1338–1340
Meinertz T, Brandstätter A, Trenk D, Jähnchen E, Ostrowski J, Gärtner W (1985) Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in man. Am Heart J 109 (3,2): 644–648
Midha KK, Roscoe RMH, Wilson TW, Cooper JK, Loo JCK, Ho-Ngoc A, McGilveray IJ (1983) Pharmacokinetics of glucuronidation of propranolol following oral administration in humans. Biopharm Drug Dispos 4: 331–338
Rowland M (1972) Influence of route of administration on drug availability. J Pharm Sci 61: 70–74
Sheiner LB, Benet LZ, Pagliaro LA (1981) Pharmacokinetic data. A standard approach to compiling clinical pharmacokinetic data. J Pharmacokinet Biopharm 9: 59–127
Snedecor GW, Cochran WG (1980) Statistical methods. Iowa State University Press, Ames, Iowa, USA, p 171
Verbeek RK (1982) Glucuronidation and disposition of drug glucuronides in patients with renal failure. Drug Metab Dispos 10: 87–89
von Hattingberg HM, Brockmeier D, Voegele D (1980) A method for in vivo — in vitro correlation using the additivity of mean times in biopharmaceutical models. In: Rietbrock N, Woodcock BG, Neuhaus G (eds) Methods in clinical pharmacology. Vieweg, Braunschweig Wiesbaden, pp 85–93
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. H.J. Dengler, Bonn, on the ocassion of his 60th birthday
Rights and permissions
About this article
Cite this article
Brockmeier, D., Ostrowski, J. Mean time and first-pass metabolism. Eur J Clin Pharmacol 29, 45–48 (1985). https://doi.org/10.1007/BF00547367
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547367